DUBLIN–(BUSINESS WIRE)–The “Intracranial Hemorrhage Devices- Market Insights, Competitive Landscape and Market Forecast-2027” report has been added to ResearchAndMarkets.com’s offering.
The global intracranial hemorrhage (ICH) devices market was valued at USD 1.59 Billion in 2021, growing at a CAGR of 6.65% during the forecast period from 2022 to 2027 to reach USD 2.35 Billion by 2027.
The increase in demand for Intracranial Hemorrhage (ICH) Devices is primarily attributed to the rising cases of brain disorders such as Stroke, Cerebral/Brain Aneurysm, the growing burden of the old age population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH Devices, thereby contributing to the growth of the Intracranial Hemorrhage (ICH) Devices market during the forecast period from 2022-2027.
Intracranial Hemorrhage (ICH) Devices Market Dynamics:
The Intracranial Hemorrhage (ICH) Devices market is witnessing a growth in product demand owing to various reasons. The major reason responsible for product demand is due to the rising burden of the patient population suffering from brain disorders such as Stroke, Cerebral/Brain Aneurysm, Intracranial Stenosis, among others across the globe is expected to fuel the demand for Intracranial hemorrhage (ICH) Devices as these devices are used to treat various conditions and diseases of the brain using minimally invasive neurosurgical techniques.
According to the World Stroke Organization 2022, globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. 13.7 million people worldwide will have their first stroke each year and five and a half million will die as a result. Also, as per the same statistics, stroke is the leading cause of death and disability globally with 116 Million years of healthy life lost each year to the disease.
Thus, the rising prevalence of the target population is anticipated to raise the demand for brain surgeries thereby increasing the demand for Intracranial hemorrhage (ICH) Devices during the forecasted period.
Therefore, with proper monitoring, these defects can be prevented by undergoing proper care and medication. Hence, the growth of the Intracranial hemorrhage (ICH) Devices Market is expected to rise during the forecast period from 2022 to 2027.
However, the risk involved with Intracranial Hemorrhage (ICH) Devices and the high cost of equipment and surgeries may be certain limiting factors of the Intracranial Hemorrhage (ICH) Devices market growth.
The market witnessed a COVID-19 outbreak which impacted the use of Intracranial hemorrhage (ICH) Devices. Intracerebral hemorrhage is a very rare but well-documented complication of COVID-19. Stroke has been seen as a manifestation of COVID-19 in various studies showing that 0.9% to 23% of COVID-19 patients developed brain stroke.
Companies Mentioned
- ClearMind Biomedical Inc.
- Medtronic
- Stryker
- InfraScan, Inc.
- MicroPort Scientific Corporation
- Penumbra, Inc.
- Acandis GmbH
- Cerenovus (Johnson & Johnson Services, Inc.)
- MicroVention Inc. (Terumo Corporation)
- Invamed
- B. Braun Melsungen AG
- adeor medical AG
- SCHINDLER Endoskopie Technologie
- Siemens Healthcare GmbH
- CANON MEDICAL SYSTEMS CORPORATION
- Kaneka Medix Corporation
- Hyperfine
- General Electric Company
- phenox GmbH
- Perflow Medical Ltd
Recent Developmental Activities in the Intracranial Hemorrhage (ICH) Devices Market:
- In February 2022, the FDA granted expanded indication to Infrascanner, a handheld device used for detecting traumatic supratentorial hematomas in adults, to include pediatric patients aged 2 years and older.
- In May 2019, Stryker announced the Premarket Approval (PMA) of the Neuroform Atlas Stent System by the U.S. Food and Drug Administration (FDA).
Key Takeaways from the Intracranial Hemorrhage (ICH) Devices Market Report Study
- Market size analysis for current Intracranial Hemorrhage (ICH) Devices market size (2020), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Intracranial Hemorrhage (ICH) Devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the global Intracranial Hemorrhage (ICH) Devices market.
- Various opportunities available for the other competitor in the Intracranial Hemorrhage (ICH) Devices market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current Intracranial Hemorrhage (ICH) Devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Intracranial Hemorrhage (ICH) Devices market growth in the coming future?
Target Audience who can be benefited from this Intracranial Hemorrhage (ICH) Devices Market Report Study
- Intracranial Hemorrhage (ICH) Devices products providers
- Research organizations and consulting companies
- Intracranial Hemorrhage (ICH) Devices-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Intracranial Hemorrhage (ICH) Devices
- Various End-users who want to know more about the Intracranial Hemorrhage (ICH) Devices market and latest technological developments in the Intracranial Hemorrhage (ICH) Devices market.
Frequently Asked Questions For Intracranial Hemorrhage (ICH) Devices Market:
1. What are Intracranial Hemorrhage (ICH) Devices?
2. What is the market for Global Intracranial Hemorrhage (ICH) Devices?
3. What are the drivers for the Global Intracranial Hemorrhage (ICH) Devices Market?
4. Who are the key players operating in the Global Intracranial Hemorrhage (ICH) Devices Market?
5. Which region has the highest share in Intracranial Hemorrhage (ICH) Devices Market?
For more information about this report visit https://www.researchandmarkets.com/r/v7iwpn
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
